1. Home
  2. LCNB vs SLDB Comparison

LCNB vs SLDB Comparison

Compare LCNB & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCNB Corporation

LCNB

LCNB Corporation

HOLD

Current Price

$16.73

Market Cap

205.5M

Sector

Finance

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$5.62

Market Cap

444.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCNB
SLDB
Founded
1877
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.5M
444.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
LCNB
SLDB
Price
$16.73
$5.62
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$14.82
AVG Volume (30 Days)
26.2K
910.5K
Earning Date
01-29-2026
11-03-2025
Dividend Yield
5.34%
N/A
EPS Growth
220.73
N/A
EPS
1.67
N/A
Revenue
$89,312,000.00
N/A
Revenue This Year
$18.04
N/A
Revenue Next Year
$4.36
N/A
P/E Ratio
$9.87
N/A
Revenue Growth
19.58
N/A
52 Week Low
$13.34
$2.41
52 Week High
$17.84
$7.37

Technical Indicators

Market Signals
Indicator
LCNB
SLDB
Relative Strength Index (RSI) 54.30 51.15
Support Level $16.32 $5.68
Resistance Level $17.59 $6.08
Average True Range (ATR) 0.42 0.37
MACD -0.10 -0.01
Stochastic Oscillator 32.17 41.51

Price Performance

Historical Comparison
LCNB
SLDB

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: